Biologic TNF-α Inhibitors for Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, and TEN-SJS Overlap: A Study-Level and Patient-Level Meta-Analysis.

Jiali Cao,Xuan Zhang,Xinzhu Xing,Jie Fan

DERMATOLOGY AND THERAPY（2023）

引用 0|浏览0

暂无评分

摘要

On the basis of the current findings, etanercept is currently the most promising biologic therapy for SJS/TEN. Further evaluation in prospective studies is required to confirm its efficacy and safety.

查看译文

关键词

Stevens–Johnson syndrome, Toxic epidermal necrolysis, Biologic, TNF-α inhibitors, Etanercept

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要